Fed Sinks Markets
Health Care: Drugs
Redhill Biopharma Ltd (RDHL: NASDAQ)
$10.55 -0.15 | -1.40%
06/19/13 - 03:18 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 29,000 | 29,000 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 29,000 | 29,000 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Portfolios with RDHL
- Portfolio NameUser Type
Latest RDHL Headlines from TheStreet
- RedHill Biopharma Submits New Drug Application To U.S. FDA For RHB-103 Anti-Migraine Oral Thin Film 03.27.13 | 06:03 am
- RedHill Biopharma Receives Positive Feedback From A Scientific Advice Meeting In Europe Regarding RHB-101 (Hypertension) Marketing Application Plan 03.19.13 | 05:03 am
- RedHill Biopharma To Present At The 25th Annual ROTH Conference 03.06.13 | 09:03 am
- RedHill Biopharma Provides Update On Development Progress And Planned NDA Submission For RHB-102 (Oncology Support Anti-Emetic) 02.25.13 | 08:02 am
- RedHill Biopharma Reports 2012 Fourth Quarter And Year-End Results 02.19.13 | 11:02 am
- RedHill Biopharma Announces Notice Of Allowance From The United States Patent And Trademark Office For Its Cardio Drug RHB-101 02.19.13 | 09:02 am
- RedHill Biopharma Announces Date Of 2012 Financial Results And Corporate Update Conference Call 02.14.13 | 09:02 am
Press Releases for RDHL
- Bioassociate Announces Valuation Report On RedHill Biopharma, Ltd. - PR Newswire 04.03.13 | 09:04 am
Partner Headlines for RDHL
